<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Bryce Foster | Goldberg Templeton | Activity</title>
	<link>https://brycefoster.com/members/europebow5/activity/</link>
	<atom:link href="https://brycefoster.com/members/europebow5/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Goldberg Templeton.</description>
	<lastBuildDate>Tue, 28 Apr 2026 12:44:07 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">09d0320d59ef51d9ef1dc6403070e4ae</guid>
				<title>Goldberg Templeton posted an update: Navigating Affordable GLP-1 Medications in Germany: A [&#133;]</title>
				<link>https://brycefoster.com/activity/p/1521939/</link>
				<pubDate>Sun, 05 Apr 2026 16:41:12 +0000</pubDate>

									<content:encoded><![CDATA[<p>Navigating Affordable GLP-1 Medications in Germany: A Comprehensive Guide</p>
<p>In the last few years, the landscape of metabolic health and weight management has actually been changed by a class of drugs known as GLP-1 receptor agonists. Standing for Glucagon-Like Peptide-1, these medications&#8211; originally established to deal with Type 2 diabetes&#8211;&hellip;<span class="activity-read-more" id="activity-read-more-1521939"><a href="https://brycefoster.com/activity/p/1521939/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">31c1d0fa9b9eac02115d4a8acb52f11f</guid>
				<title>Goldberg Templeton became a registered member</title>
				<link>https://brycefoster.com/activity/p/1521892/</link>
				<pubDate>Sun, 05 Apr 2026 16:29:26 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>